OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Thyssenkrupp Nucera AG & Co KGaa/  DE000NCA0001  /

Cboe Europe DXE
08/11/2024  17:29:58 Chg. -0.46 Volume Bid17:30:00 Ask17:30:00 Market Capitalization Dividend Y. P/E Ratio
9.34EUR -4.67% 23,291
Turnover: 132,542.46		 -Bid Size: - -Ask Size: - 927.5 mill.EUR - 154.58

Business description

Thyssenkrupp nucera AG & Co. KGaA operates as a green hydrogen electrolysis technology company. The Company specializes in engineering, procurement, and construction of electrochemical plants and providing green hydrogen, chlor-alkali, and hydrochloric acid solutions. thyssenkrupp nucera serves clients worldwide.
 

Management board & Supervisory board

CEO
Dr. Werner Ponikwar
Management board
Dr. Arno Pfannschmidt, Fulvio Federico
Supervisory board
Dr. Volkmar Dinstuhl, Paolo Dellachà, Jennifer Cooper, Markus Fuhrmann, Michael Höllermann, Dr. Arnd Köfler, Dr. Sebastian Lochen, Miguel Ángel López Borrego, Prof. Dr. Franca Ruhwedel, Dr. Robert Scannell
 

Company data

Name: THYSSENKRUPP NUCERA O.N.
Address: Vosskuhle 38, Harpen-Haus,44141 Dortmund
Phone: -
Fax: -
E-mail: dortmund@thyssenkrup...era.com dortmund@thyssenkrupp-nucera.com
Internet: https://thyssenkrupp-nucera.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 30/09
Free Float: 17.96%
IPO date: 07/07/2023

Investor relations

Name: Dr. Hendrik Finger
IR phone: +49 231 229 724 347
IR Fax: -
IR e-mail: ir@thyssenkrupp-nucera.com

Company calendar

CW 51 | 17/12/2024 Annual Report
 

Main Shareholders

thyssenkrupp AG
 
 50.19%
De Nora S.p.A.
 
 25.85%
FreeFloat
 
 17.96%
Energy Solutions Company
 
 6.00%